Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-013453
Filing Date
2021-02-23
Accepted
2021-02-23 19:13:36
Documents
1
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4228
  Complete submission text file 0001209191-21-013453.txt   5720
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O UNITEDHEALTH GROUP INCORPORATED 9900 BREN ROAD EAST MINNETONKA MN 55123
Business Address
Tuckson Reed Vaughn (Reporting) CIK: 0001511051 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 21667748